Herpes Simplex Virus pp 57-72 | Cite as
Herpes Simplex Virus Growth, Preparation, and Assay
Protocol
First Online:
- 3 Citations
- 1.4k Downloads
Abstract
The human herpesvirus family members, in particular herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2), are abundant and extremely contagious viruses with a high seroprevalence in the human population emphasizing the importance of studying their biology. Hence, the propagation and purification of virus stocks constitute a key element in laboratory work.
Key words
HSV growth Plaque purification Plaque titration Growth curve Virus stock PurificationReferences
- 1.Beswick TSL (1962) The origin and the use of the word herpes. Med Hist 6:214–232CrossRefGoogle Scholar
- 2.Segura MM, Kamen AA, Garnier A (2011) Overview of current scalable methods for purification of viral vectors. In: Merten O-W, Al-Rubeai M (eds) Viral vectors for gene therapy: methods and protocols. Humana, Totowa, NJ, pp 89–116CrossRefGoogle Scholar
- 3.Mundle ST, Hernandez H, Hamberger J et al (2013) High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo. PLoS One 8:e57224CrossRefGoogle Scholar
- 4.Vahlne AG, Blomberg J (1974) Purification of herpes simplex virus. J Gen Virol 22:297–302CrossRefGoogle Scholar
- 5.Knop DR, Harrell H (2008) Bioreactor production of recombinant herpes simplex virus vectors. Biotechnol Prog 23:715–721CrossRefGoogle Scholar
- 6.Jiang C, Wechuck JB, Goins WF et al (2004) Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. J Virol 78:8994–9006CrossRefGoogle Scholar
- 7.Kärber G (1931) Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Naunyn-Schmiedebergs Arch Für Exp Pathol Pharmakol 162:480–483CrossRefGoogle Scholar
- 8.Spearman C (1908) The method of “right and wrong cases” (constant stimuli) without Gauss’s formula. J Psychol 2:227–242Google Scholar
- 9.Ozuer A, Wechuck JB, Goins WF et al (2002) Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnol Bioeng 77:658–692CrossRefGoogle Scholar
Copyright information
© Springer Science+Business Media, LLC, part of Springer Nature 2020